Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma
- PMID: 31504916
- PMCID: PMC7188227
- DOI: 10.1093/rheumatology/kez341
Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma
Abstract
Objective: To investigate the natural history of fibrotic lung disease in recipients of a single lung transplant for scleroderma-associated interstitial lung disease (ILD).
Methods: Global ILD (including ground glass, nodular opacities and fibrosis) was categorized into severity quintiles on first and last post-transplant CT scans, and percent fibrosis by manual contouring was also determined, in nine single lung transplant recipients. Quantitative mean lung densities and volumes for the native and allograft lungs were also acquired.
Results: In the native lung, global ILD severity quintile worsened in two cases and percent fibrosis worsened in four cases (range 5-28%). In the lung allograft, one case each developed mild, moderate and severe ILD; of these, new fibrotic ILD (involving <10% of lung) occurred in two cases and acute cellular rejection occurred in one. The average change in native lung density over time was +2.2 Hounsfield Units per year and lung volume +1.4 ml per year, whereas the allograft lung density changed by -5.5 Hounsfield Units per year and total volume +27 ml per year (P = 0.011 and P = 0.039 for native vs allograft density and volume comparisons, respectively).
Conclusions: While the course of ILD in the native and transplanted lungs varied in this series, these cases illustrate that disease progression is common in the native lung, suggesting that either the immune process continues to target autoantigens or ongoing fibrotic pathways are active in the native lung. Mild lung disease may occur in the allograft after several years due to either allograft rejection or recurrent mild ILD.
Keywords: CT imaging; interstitial lung disease; longitudinal; lung transplant; pulmonary fibrosis; scleroderma; systemic sclerosis.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures


References
-
- Schurawitzki H, Stiglbauer R, Graninger W. et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 1990;176:755–9. - PubMed
-
- Steen VD, Conte C, Owens GR, Medsger TA Jr.. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994;37:1283–9. - PubMed
-
- Schachna L, Medsger TA Jr, Dauber JH. et al. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum 2006;54:3954–61. - PubMed
-
- Massad MG, Powell CR, Kpodonu J. et al. Outcomes of lung transplantation in patients with scleroderma. World J Surg 2005;29:1510–5. - PubMed
-
- Crespo MM, Bermudez CA, Dew MA. et al. Lung transplant in patients with scleroderma compared with pulmonary fibrosis. short- and long-term outcomes. Ann Am Thorac Soc 2016;13:784–92. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical